(Q39676787)

13 September 2017

title

Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitis (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB01682.X

28 April 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB01682.X

28 April 2022

author name string

W. Weimar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A111947

28 April 2022

R. A. Heijtink

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A111947

28 April 2022

S. W. Schalm

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A111947

28 April 2022

H. Schellekens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A111947

28 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=111947

28 April 2022

publication date

1 April 1979

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2362.1979.tb01682.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB01682.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2362.1979.tb01682.x/fullpdf

28 April 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB01682.X

European Journal of Clinical Investigation

28 April 2022

published in

1 reference

13 September 2017

volume

9

1 reference

13 September 2017

issue

2 Pt 1

1 reference

13 September 2017

page(s)

151-154

1 reference

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB01682.X

Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB01682.X

Administration of human fibroblast interferon in chronic hepatitis-B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB01682.X

Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB01682.X

Fibroblast interferon in HBsAg-positive chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB01682.X

The mechanism of inhibition of reovirus replication by interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB01682.X

Relationship Between the Physicochemical Nature of Human Interferon, the Cell Induced, and the Inducing Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB01682.X

Two antigenically distinct species of human interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB01682.X

Multiple active sites on human interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB01682.X

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

21 January 2018

4

295

517

Greenberg H.B.

1976

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB01682.X

Mass production of human interferon in diploid cells stimulated by poly-I:C

28 April 2022

8

19

1

Billiau A.

1973

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB01682.X

The role of immunological mechanisms in acute and chronic hepatitis

28 April 2022

13

50

348

Eddleston A.L.W.F.

1974

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB01682.X

Human Fibroblast and Leukocyte Interferons Show Different Dose-Response Curves in Assay of Cell Protection

28 April 2022

16

31

251

Edy V.G.

1976

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB01682.X

Antiviral activity of interferons

28 April 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB01682.X

26 November 2022

Identifiers

1 reference

13 September 2017

1 reference